Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
European Journal of Nutrition
Literature
1.
Zanella I, Marrazzo E, Biasiotto G, Penza M, Romani A, Vignolini P, Caimi L, Di Lorenzo D (2014) Soy and the soy isoflavone genistein promote adipose tissue development in male mice on a low-fat diet. Eur J Nutr Oct 24. doi:10.​1007/​s00394-014-0786-9 (in press)
2.
Zhang M, Ikeda K, Xu JW, Yamori Y, Gao XM, Zhang BL (2009) Genistein suppresses adipogenesis of 3T3-L1 cells via multiple signal pathways. Phytother Res 23(5):713–718CrossRef
3.
Jung SR, Kim YJ, Gwon AR, Lee J, Jo DG, Jeon TJ, Hong JW, Park KM, Park KW (2011) Genistein mediates the anti-adipogenic actions of Sophora japonica L. extracts. J Med Food 14(4):360–368CrossRef
4.
Taxvig C, Specht IO, Boberg J, Vinggaard AM, Nellemann C (2013) Dietary relevant mixtures of phytoestrogens inhibit adipocyte differentiation in vitro. Food Chem Toxicol 55:265–271CrossRef
5.
Gardner CD, Chatterjee LM, Franke AA (2009) Effects of isoflavone supplements vs. soy foods on blood concentrations of genistein and daidzein in adults. J Nutr Biochem 20(3):227–234CrossRef
6.
Franke AA, Lai JF, Halm BM (2014) Absorption, distribution, metabolism, and excretion of isoflavonoids after soy intake. Arch Biochem Biophys 559:24–28CrossRef
7.
Strakovsky RS, Lezmi S, Flaws JA, Schantz SL, Pan YX, Helferich WG (2014) Genistein exposure during the early postnatal period favors the development of obesity in female, but not male rats. Toxicol Sci 138(1):161–174CrossRef
8.
Nadal-Casellas A, Proenza AM, Lladó I, Gianotti M (2012) Sex-dependent differences in rat hepatic lipid accumulation and insulin sensitivity in response to diet-induced obesity. Biochem Cell Biol 90(2):164–172CrossRef
9.
Relic B, Zeddou M, Desoroux A, Beguin Y, de Seny D, Malaise MG (2009) Genistein induces adipogenesis but inhibits leptin induction in human synovial fibroblasts. Lab Invest 89(7):811–822CrossRef
10.
Wang L, Waltenberger B, Pferschy-Wenzig EM, Blunder M, Liu X, Malainer C, Blazevic T, Schwaiger S, Rollinger JM, Heiss EH, Schuster D, Kopp B, Bauer R, Stuppner H, Dirsch VM, Atanasov AG (2014). Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a review. Biochem Pharmacol 30 Jul 2014. doi:10.​1016/​j.​bcp.​2014.​07.​018 (in press)
11.
12.
Lee JY, Hashizaki H, Goto T, Sakamoto T, Takahashi N, Kawada T (2011) Activation of peroxisome proliferator-activated receptor-α enhances fatty acid oxidation in human adipocytes. Biochem Biophys Res Commun 407(4):818–822CrossRef
Metadata
Title
Genistein as a nature-derived PPAR agonist in adipogenesis and weight gain
Author
Salvatore Chirumbolo
Publication date
01-04-2015
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Nutrition / Issue 3/2015
Print ISSN: 1436-6207
Electronic ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-015-0848-7

Other articles of this Issue 3/2015

European Journal of Nutrition 3/2015 Go to the issue

Original Contribution

Mechanisms underlying the beneficial effect of soy protein in improving the metabolic abnormalities in the liver and skeletal muscle of dyslipemic insulin resistant rats

Original Contribution

Association between different obesity measures and the risk of stroke in the EPIC Spanish cohort

Original Contribution

Independent positive association of plasma β-carotene concentrations with adiponectin among non-diabetic obese subjects

Original Contribution

Effect of acute beer ingestion on the liver: studies in female mice

Original Contribution

Probiotics during weaning: a follow-up study on effects on body composition and metabolic markers at school age

Original Contribution

Combination of β-carotene and quercetin against benzo[a]pyrene-induced pro-inflammatory reaction accompanied by the regulation of antioxidant enzyme activity and NF-κB translocation in Mongolian gerbils
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits